Erlotinib/gefitinib/osimertinibDevelopment of resistance in non-small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1850卷 / 1期
关键词：
D O I：
10.1007/s40278-021-93936-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：131 / 131
相关论文
共 50 条
  • [31] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Kaye, Frederic J.
    Jantz, Michael A.
    Dallas, Jennifer
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [32] Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
    Togashi, Yosuke
    Masago, Katsuhiro
    Masuda, Satohiro
    Mizuno, Tomoyuki
    Fukudo, Masahide
    Ikemi, Yasuaki
    Sakamori, Yuichi
    Nagai, Hiroki
    Kim, Young Hak
    Katsura, Toshiya
    Mishima, Michiaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (03) : 399 - 405
  • [33] Phase II Study of Erlotinib for Acquired Resistance to Gefitinib in Patients with Advanced Non-small Cell Lung Cancer
    Horiike, Atsushi
    Yamamoto, Nobuyuki
    Tanaka, Hisashi
    Yanagitani, Noriko
    Kudo, Keita
    Ohyanagi, Fumiyoshi
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2014, 34 (04) : 1975 - 1981
  • [34] Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer
    Horiike, A.
    Yamamoto, N.
    Tanaka, H.
    Yanagitani, N.
    Kudo, K.
    Ohyanagi, F.
    Naito, T.
    Murakami, H.
    Horai, T.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Combination of quinacrine and erlotinib overcomes resistance to erlotinib in non-small cell lung cancer
    Dermavvan, Josephine Kam Tai
    Gurova, Katerina
    Pink, John
    Dowlati, Afshin
    De, Sarmishtha
    Naria, Goutham
    Sharma, Neelesh
    Stark, George
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [36] Gefitinib in non-small cell lung cancer
    Tamura, K
    Fukuoka, M
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (06) : 985 - 993
  • [37] MicroRNA markers for erlotinib resistance in non-small cell lung cancer
    Nelson, Kristen
    Ranade, Aarati
    Kashey, Trevor
    Kingsley, Chris
    Weiss, Glen
    CANCER RESEARCH, 2009, 69
  • [38] Erlotinib after failure of gefitinib in patients with advanced non-small cell lung cancer previously responding to gefitinib
    Vasile, Enrico
    Tibaldi, Carmelo
    Chella, Antonio
    Falcone, Alfredo
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 912 - 914
  • [39] AlectinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1682 (1) : 24 - 24
  • [40] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2019, 1754 (1) : 120 - 120
12345